Keith H Baggaley

This inventor holds 19 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Beecham Group Plc, Smithkline Beecham Corporation. Active years: 1976-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith H Baggaley. Retrieved from https://idiyas.com/inventor/keith-h-baggaley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19

% Patents Active = 100.0

Average Co-Inventor Count = 1.8

ph-index = 6

Forward Citations = 151(Granted Patents)

Location History:

Redhill, EN (1976 - 1978)
Betchworth, GB (1989 - 1992)
Redhill, GB (1978 - 1999)

Company Filing History:

Smithkline Beecham Corporation

patents

Years Active: 1976-1999

Loading Chart...

Areas of Expertise:

Clavulanic Acid

Hypolipidaemic Compounds

Platelet Aggregation

Benzisothiazolones

Prostacyclin Analogs

Enzymatic Preparation

Polycyclic Compounds

Thrombosis Treatment

Chemical Derivatives

Pharmaceutical Compositions

Aza Analogues

Oxy-Aromatic Acids

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5869299 - Process for producing clavulanic acid (1999-02-09),

2. 5130241 - Clavam derivatives and its enzymatic preparation (1992-07-14),

3. 4795809 - Novel clavam derivatives and methods of making same (1989-01-03),

4. 4362892 - Hypolipidaemic compounds (1982-12-07),

5. 4350702 - Method of inhibiting platelet aggregation (1982-09-21),

6. 4341708 - Prostacyclin aza analogue intermediates (1982-07-27),

7. 4262008 - 2,4-Disubstituted 5-oxo-5H-hexahydrofuro[3,2b]pyrroles (1981-04-14),

8. 4243669 - 2-Substituted benzisothiazolones (1981-01-06),

9. 4212979 - 2-Substituted benzisothiazolones (1980-07-15),

10. 4212872 - 2-Substituted benzisothiazolones and use thereof (1980-07-15),

11. 4206145 - Hypolipidaemic compounds and compositions (1980-06-03),

12. 4186203 - 2-[Gamma-(1-piperidinyl)propyl]-1,2-benzisothiazole-3-one, its salts, (1980-01-29),

13. 4182768 - Prophylaxis or treatment of thromboses and inhibition of platelet (1980-01-08),

14. 4154850 - Certain di-(substituted phenoxy) alkanes and hypolipidaemic use thereof (1979-05-15),

15. 4113728 - 2-Substituted benzisothiazolones (1978-09-12),

Title: The Innovative Path of Inventor Keith H Baggaley

Introduction

Keith H Baggaley, an accomplished inventor based in Redhill, GB, has made significant contributions to the field of biochemistry and pharmaceuticals. With a remarkable portfolio that includes 19 patents, Baggaley's innovative spirit has been instrumental in advancing scientific knowledge and industry practices.

Latest Patents

Among his latest patents, Baggaley has developed a process for producing clavulanic acid and its derivatives. This patent describes a compound having a specific formula, alongside its salts, and introduces an enzymatic process for converting such compounds into clavulanic acid. Notably, this process utilizes a novel enzyme system derived from microorganisms, particularly a species of Streptomyces, to achieve the desired cyclization. His work in this area showcases his dedication to enhancing pharmaceutical products and methods.

Career Highlights

Throughout his career, Keith H Baggaley has collaborated with prominent organizations in the pharmaceutical sector. He has worked with Beecham Group Plc and SmithKline Beecham Corporation, where his innovative ideas and expertise have contributed to significant advancements in drug development and production processes.

Collaborations

During his professional journey, Baggaley has teamed up with notable colleagues, including Brian Morgan and Richard M Hindley. These collaborations have played a crucial role in his success, fostering an environment of creativity and shared knowledge that drives innovation forward.

Conclusion

In summary, Keith H Baggaley's exceptional contributions to the field of pharmaceuticals through his inventions and patents reflect his remarkable talent and dedication. His groundbreaking work continues to influence the industry, inspiring future innovations and paving the way for new discoveries in biochemistry.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]